Unlocking Value and Expanding Growth: McNally Capital's Sale of Advanced Micro Instruments, Inc. to Enpro Inc.
Gracie Gottlieb | 3 January, 2024
In a compelling move that highlights McNally Capital's commitment to driving value creation and empowering businesses, the private equity firm has successfully entered into a purchase agreement for the sale of Advanced Micro Instruments, Inc. (AMI) to Enpro Inc. (NYSE: NPO). This strategic transaction opens an exciting new chapter for both companies and solidifies AMI's position as a leading provider of cutting-edge analyzers and sensing technologies.
AMI, based in Costa Mesa, California, specializes in highly engineered, application-specific analyzers and sensing technologies. With a portfolio of oxygen, hydrogen sulfide, and moisture analyzers, as well as proprietary sensing capabilities, AMI serves a diverse range of industries including midstream natural gas, biogas, industrial processing, cryogenics, food processing, laboratory, wastewater, and aerospace. Their solutions play a crucial role in monitoring critical parameters, maintaining infrastructure integrity, promoting process efficiency, enhancing safety, and facilitating the clean energy transition.
Under the stewardship of McNally Capital, AMI has thrived in various aspects. The partnership facilitated revolutionary product development, organic growth, and the diversification of client and distribution bases. The widespread industry adoption of AMI's products has driven tremendous value creation for the company. The strategic sale to Enpro Inc. further bolsters AMI's growth trajectory, reinforcing their position as industry leaders.
The success of this transaction is a testament to McNally Capital's differentiated investment strategy. By leveraging their industry expertise, McNally Capital has consistently supported and enhanced the growth journey of founder-owned businesses. They bring a solutions-focused approach to accelerate business growth, generating optimal outcomes for both investors and management teams.
Adam Lerner, Partner of McNally Capital, acknowledged the impact of McNally Capital's value creation process. Throughout the transaction lifecycle, their commitment to driving success has directly influenced investors and management teams. Lerner highlights the significance of industry expertise in partnering with founders and management owners. This approach has proven invaluable in supporting and enhancing the growth of privately-held businesses.
Kevin Bates, President and CEO of AMI, expressed enthusiasm for joining the Enpro family. He credits McNally Capital for strategically fostering a strong position for AMI, establishing them as industry leaders. This exciting next chapter for AMI is a testament to the impactful growth experienced through their partnership with McNally Capital.
McNally Capital's investment strategy centers around thesis-driven investments in the U.S., specifically targeting founder- and management-owned companies. By focusing on the Aerospace & Defense/National Security, Industrial Products & Services, and Business Services industries, McNally Capital aims to invest in lower middle-market businesses with $5 million to $20 million in EBITDA. Their deep bench of industry partners provides incremental industry and operating knowledge and expertise, further bolstering the success of their investments.
The transaction between McNally Capital and Enpro Inc. is set to close in early 2024, pending limited closing conditions and regulatory approvals. This exciting development marks another significant milestone for both companies, solidifying their positions in the market and unlocking new opportunities for growth.
In conclusion, McNally Capital's sale of Advanced Micro Instruments, Inc. to Enpro Inc. represents a strategic move that maximizes value creation and propels AMI into a new phase of growth. McNally Capital's commitment to driving success and their differentiated investment strategy have positioned them as industry leaders in supporting founder-owned businesses. As AMI embarks on a new journey with Enpro Inc., the future looks promising for both companies, as they continue to deliver innovative solutions and drive positive change in their respective industries.
About McNally Capital
McNally Capital is a lower middle-market private equity firm dedicated to acquiring founder and management-owned companies in the U.S. With a focus on upholding a 160+ year legacy as a family-owned and operated company, McNally Capital leverages hands-on experience, institutional capabilities, and a proprietary value creation framework to benefit management teams in their next phase of growth. For more information, please visit www.mcnallycapital.com.
About Advanced Micro Instruments, Inc.
Advanced Micro Instruments, Inc. (AMI) is a leading provider of highly engineered, application-specific analyzers and sensing technologies. Based in Costa Mesa, California, AMI serves customers in various industries, including midstream natural gas, biogas, industrial processing, cryogenics, food processing, laboratory, wastewater, and aerospace. Their portfolio of analyzers and sensing capabilities enables operators to detect contaminants and ensure optimal process efficiency, safety, and environmental sustainability. For more information, please visit www.amio2.com.
Other Posts
- The Power of Holding: How Verity & Verity, LLC's Q4 2022 vs. Q1 2023 13F Holdings Comparison Reflects Changes in Investment Strategy
- American Pacific Group Accelerates Growth with Investment in Spark Power
- Crestwood Advisors Group LLC Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Leixir Dental Laboratory Group Welcomes John Krier as CEO
- Navigating the Alloy of Opportunity: Blue Sage Capital's Strategic Investment in American Alloy
- Unveiling the Investment Strategy Shift: A Deep Dive into Cypress Wealth Services' Portfolio Evolution
- Navigating the Winds of Change: How Financial Enhancement Group's Portfolio Transformed from Q4 2023 to Q1 2024
- Exploring the Financial Landscape: Dissecting Anderson Hoagland & Co's Latest Investment Moves
- Cosette Pharmaceuticals Brings Affordable Alternative to Women's Health Market with Metronidazole Vaginal Gel 0.75%
- Arrow Investment Advisors' Q3 2022 vs. Q4 2022 Holdings: An Extensive Analysis